VAERS reports by lot

GSK Varicella/Shingles lot 52R7X: VAERS reports

66 VAERS reports list lot 52R7X as a GSK Varicella/Shingles vaccine, received between 2019-07-19 and 2021-11-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
66
Reports
9%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5728%
General / Systemic (non-local)4823%
Dermatological (non-injection-site)2412%
Neurological2211%
Musculoskeletal189%
Allergic / Anaphylactic178%
Cardiac / Cardiovascular105%
Gastrointestinal63%
Respiratory42%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Missouri8
Pennsylvania6
Washington4
Georgia4
Florida4
Ohio3
Arkansas3
Tennessee3
Massachusetts3
Oklahoma2
South Carolina2
Texas2

Reports by month received

2019-0712
2019-0823
2019-0915
2019-103
2019-112
2019-123
2020-021
2020-061
2020-081
2020-111
2020-122
2021-081
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.